Literature DB >> 11113420

Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.

T Van Noord1, I C Van Gelder, B A Schoonderwoerd, H J Crijns.   

Abstract

Ninety-one percent of patients with atrial fibrillation (AF) resisting electrical cardioversion because of immediate reinitiation of AF after the shock maintain long-term sinus rhythm with amiodarone and repeat cardioversion. Thus, immediate reinitiation of AF is an important sign that should guide further treatment in patients with electrical cardioversion-resistant AF.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11113420     DOI： 10.1016/s0002-9149(00)01250-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  7 in total

1.  Analysis of electrical and mechanical left atrial properties in patients with persistent atrial fibrillation.

Authors:  Anna Degiovanni; Miriam Bortnik; Gabriele Dell'Era; Virginia Bolzani; Eraldo Occhetta; Giorgio Bellomo; Paolo Marino
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-29       Impact factor: 2.357

2.  [Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference].

Authors:  P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

3.  Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.

Authors:  Anna Nergärdh; Rolf Nordlander; Mats Frick
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

Review 4.  Surgical Ablation of Atrial Fibrillation Using Energy Sources.

Authors:  Alexandre Visconti Brick; Domingo Marcolino Braile
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

Review 5.  Cardioversion in Non-Valvular Atrial Fibrillation.

Authors:  Hermann H Klein; Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2015-12-11       Impact factor: 5.594

6.  Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.

Authors:  Andreas Müssigbrodt; Silke John; Jedrzej Kosiuk; Sergio Richter; Gerhard Hindricks; Andreas Bollmann
Journal:  Europace       Date:  2015-06-07       Impact factor: 5.214

7.  Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure.

Authors:  Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.